PB1766: IN VITRO ACQUIRED RESISTANCE TO THE ORAL MYELOID KINASE INHIBITOR TUSPETINIB CREATES SYNTHETIC LETHAL VULNERABILITY TO VENETOCLAX

Detalles Bibliográficos
Autores principales: Sonowal, Himangshu, Bejar, Rafael, Rice, William, Howell, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429962/
http://dx.doi.org/10.1097/01.HS9.0000973920.30384.d0
_version_ 1785090841850675200
author Sonowal, Himangshu
Bejar, Rafael
Rice, William
Howell, Stephen
author_facet Sonowal, Himangshu
Bejar, Rafael
Rice, William
Howell, Stephen
author_sort Sonowal, Himangshu
collection PubMed
description
format Online
Article
Text
id pubmed-10429962
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104299622023-08-17 PB1766: IN VITRO ACQUIRED RESISTANCE TO THE ORAL MYELOID KINASE INHIBITOR TUSPETINIB CREATES SYNTHETIC LETHAL VULNERABILITY TO VENETOCLAX Sonowal, Himangshu Bejar, Rafael Rice, William Howell, Stephen Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429962/ http://dx.doi.org/10.1097/01.HS9.0000973920.30384.d0 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Sonowal, Himangshu
Bejar, Rafael
Rice, William
Howell, Stephen
PB1766: IN VITRO ACQUIRED RESISTANCE TO THE ORAL MYELOID KINASE INHIBITOR TUSPETINIB CREATES SYNTHETIC LETHAL VULNERABILITY TO VENETOCLAX
title PB1766: IN VITRO ACQUIRED RESISTANCE TO THE ORAL MYELOID KINASE INHIBITOR TUSPETINIB CREATES SYNTHETIC LETHAL VULNERABILITY TO VENETOCLAX
title_full PB1766: IN VITRO ACQUIRED RESISTANCE TO THE ORAL MYELOID KINASE INHIBITOR TUSPETINIB CREATES SYNTHETIC LETHAL VULNERABILITY TO VENETOCLAX
title_fullStr PB1766: IN VITRO ACQUIRED RESISTANCE TO THE ORAL MYELOID KINASE INHIBITOR TUSPETINIB CREATES SYNTHETIC LETHAL VULNERABILITY TO VENETOCLAX
title_full_unstemmed PB1766: IN VITRO ACQUIRED RESISTANCE TO THE ORAL MYELOID KINASE INHIBITOR TUSPETINIB CREATES SYNTHETIC LETHAL VULNERABILITY TO VENETOCLAX
title_short PB1766: IN VITRO ACQUIRED RESISTANCE TO THE ORAL MYELOID KINASE INHIBITOR TUSPETINIB CREATES SYNTHETIC LETHAL VULNERABILITY TO VENETOCLAX
title_sort pb1766: in vitro acquired resistance to the oral myeloid kinase inhibitor tuspetinib creates synthetic lethal vulnerability to venetoclax
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429962/
http://dx.doi.org/10.1097/01.HS9.0000973920.30384.d0
work_keys_str_mv AT sonowalhimangshu pb1766invitroacquiredresistancetotheoralmyeloidkinaseinhibitortuspetinibcreatessyntheticlethalvulnerabilitytovenetoclax
AT bejarrafael pb1766invitroacquiredresistancetotheoralmyeloidkinaseinhibitortuspetinibcreatessyntheticlethalvulnerabilitytovenetoclax
AT ricewilliam pb1766invitroacquiredresistancetotheoralmyeloidkinaseinhibitortuspetinibcreatessyntheticlethalvulnerabilitytovenetoclax
AT howellstephen pb1766invitroacquiredresistancetotheoralmyeloidkinaseinhibitortuspetinibcreatessyntheticlethalvulnerabilitytovenetoclax

Ejemplares similares